Clinical Trial Update: Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prophylactic lymphatic reconstruction to prevent lymphedema after node dissection for malignant skin neoplasms; status current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphedema of Limb
• Malignant Skin Neoplasm

Snippet

Sponsor: Alberta Health Services, Calgary | Conditions: Lymphedema of Limb, Malignant Skin Neoplasm | Phase 3 | Status: UNKNOWN